Mary Lincoln Campbell
Managing Director @ EDF Ventures
Mary Lincoln Campbell is a Series A investor at EDF Ventures focused on Health Care and Medical Device. Mary is a Managing Director and Founder of EDF Ventures. She has been an active investor both in healthcare and information technology companies for over 20 years.Currently, Mary sits on the boards of the following companies:Arxan Technologies, a company developing next generation anti-tamper solutions to enable software programs to nullifysoftware tampering and piracy;IntelePeer, a VoIP based interconnection, gateway and enhanced telephony services for VoIP and PSTN private/local exchange carriers; andValenTx, a medical device company treating morbid obesityShe is also a board observer for the following companies:Cerenis Therapeutics, a developer of drugs for the treatment of cardiovascular and metabolic diseases; andLycera, a pharmaceutical company developing drugs to fight diseases of the immune systemMary led several of the firm's most successful transactions including: Pixelworks, a leader of system-on-a-chip integrated circuits for the advanced display market which became a public company; HandyLab, a developer of molecular diagnostic assays and automation platforms, sold to Becton Dickinson & Company; Sircon, a provider of automation solutions for the insurance industry, sold to Vertafore the nation’s number one insurance software provider; and Greenplum, a database clustering software for business intelligence and data warehousing, sold to EMC Corporation, the world’s leading provider of information infrastructure solutions. Mary is active with The Stephen M. Ross School of Business at The University of Michigan and currently serves as an advisor to the Zell Lurie Institute for Entrepreneurial Studies as well as its student-run venture activity, the Wolverine Venture Fund. She is an advisor to The University of Michigan's Life Science Institute and she serves on the advisory board of The Charles F. Dolan School of Business at Fairfield University. Mary has also served as past President and board member of the Michigan Venture Capital Association, the State's premier public policy advocate for the private equity/venture capital industry.Mary received her MBA from The University of Michigan; her MA in Special Education from Fairfield University; and her BA in English from The University of Michigan.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Mary Lincoln Campbell invests in
Stages Mary Lincoln Campbell invests in
Countries Mary Lincoln Campbell invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Medical Device 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Funding Round 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ValenTx
|
ValenTx is a development-stage medical device company that focuses on minimally-invasive methods for the treatment of morbid obesity. The company was founded in 2002 and headquartered in Maple Grove, Minnesota. | $22M / Series B / Sep 08, 2009 | |
|
ValenTx
|
ValenTx is a development-stage medical device company that focuses on minimally-invasive methods for the treatment of morbid obesity. The company was founded in 2002 and headquartered in Maple Grove, Minnesota. | $6.1M / Series A / Aug 03, 2006 | |
Centromine
|
Centromine offers a browser-based, internet-accessed, enterprise-wide software applications and services for the health care market. Its applications allow behavioral health care programs and providers to manage the delivery and associated quality and cost of services completely over the internet. | $5.1M / Nov 02, 1999 |
Co-Investors
Affinity Capital Management
1 deal together
affinity ventures
1 deal together
Covidien Ventures
1 deal together
Kaiser Permanente Ventures
1 deal together
Piper Sandler
1 deal together
Sapient Capital Management
1 deal together
About EDF Ventures
EDF Ventures is a leading venture capital firm investing in early-stage healthcare companies.
EDF Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Mary Lincoln Campbell
Managing Director
|
|||
Jim Adox
Team Member
|
|||
Mary Campbell
Managing Director
|
|||
Mike DeVries
Managing Director
|
|||
Mike DeVries
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Mary Lincoln Campbell invest in?
Mary Lincoln Campbell invests primarily in Health Care and Medical Device startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Mary Lincoln Campbell last invest?
The most recent investment recorded for Mary Lincoln Campbell closed in Sep 2009. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
